DEF: agilon health 2026 Proxy Statement Overview

agilon health's 2026 proxy statement outlines leadership transitions, executive compensation adjustments, and strategic focus on profitability.

Summary

• The company reported 2025 revenue of $5.93 billion, a medical margin of negative $56.6 million, and a Reported Adjusted EBITDA loss of $296.2 million.
• Approximately 75% of patients on the agilon platform are expected to be in 4+ STAR plans for the 2027 payment year.
• The company is prioritizing margin over membership growth and has implemented restructuring actions to streamline costs.
• A 1-for-25 reverse stock split was effected on March 30, 2026.
• The company is currently searching for a permanent Chief Executive Officer following the resignation of Steven Sell in July 2025.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a cautious outlook, reflecting a company in transition, dealing with significant financial losses, and searching for a new CEO, though management is taking decisive steps to stabilize the business.

Positives

• Approximately 75% of patients are expected to be in 4+ STAR plans, an increase from 71% in the 2026 payment year.
• The company achieved a consolidated average of 4.2 Stars across markets for the 2026 STAR ratings.
• The palliative care program has expanded and achieved a Net Promoter Score of +88.
• The company has upgraded its data pipeline to improve clinical and financial analytics.

Negatives

• Reported 2025 revenue of $5.93 billion with a medical margin of negative $56.6 million.
• Reported Adjusted EBITDA loss of $296.2 million for 2025.
• Profitability was pressured by lower risk adjustment revenue, strategic market exits, and elevated cost trends.
• The company has a history of net losses and expects expenses to increase in the future.

Risks

• Failure to identify and develop successful new geographies, physician partners, and payors.
• Medical expenses incurred on behalf of members may exceed revenues received.
• Significant reduction in membership.
• Inaccuracy in estimates of members' risk adjustment factors, medical services expense, and incurred but not reported claims.
• Reliance on a limited number of key payors and the limited terms of contracts with them.
• Potential for security breaches, cybersecurity attacks, and loss of data.
• Dependence on federal government healthcare programs and potential changes to them.

Future Outlook

The company is focused on disciplined execution to strengthen its foundation, prioritizing margin over membership growth, optimizing payor contracting, and improving medical cost management to restore margin expansion and profitability in 2026 and beyond.

Management Comments

• Seniors deserve better care. Communities benefit when health care is delivered locally, thoughtfully and with accountability.
• We believe agilons scale and durability of our platform position us to play a meaningful role in this transformation.
• The Committee believes these actions are critical to restoring margin expansion and positioning the Company for improved profitability in 2026 and beyond.

Industry Context

StockSavvy.ai notes that agilon health is navigating a challenging environment for value-based care providers, characterized by elevated medical utilization and regulatory pressure on risk adjustment revenue, forcing a strategic pivot from aggressive membership growth to operational discipline and margin improvement.

Comparison to Industry Standards

• The company's 4+ STAR plan expectation of 75% is above the overall Medicare Advantage market average of 65%.
• The company's executive compensation program incorporates clawback policies and stock ownership guidelines consistent with industry best practices.
• The company's shift to a three-year ratable vesting schedule for equity awards aligns with peer practices.

Management Changes

Corporate Governance

Legal Proceedings

• None disclosed in the filing.

Related Party Transactions

• The company incurred $8.4 million in expenses for palliative care services provided by Illumia Health, LLC, which is owned by Gentiva Health Services, a company controlled by CD&R.

Stakeholder Impact

• Stockholders are asked to vote on director elections, auditor ratification, and executive compensation.
• Employees are subject to restructuring actions and changes in compensation structure.
• Physician partners are central to the company's Total Care Model and are impacted by the shift in growth strategy.

Next Steps

• Hold 2026 Annual Meeting of Stockholders on June 2, 2026.
• Continue search for a permanent Chief Executive Officer.
• Execute transformation initiatives to improve profitability in 2026.

Key Dates

Recommendation

The company is in a significant transition phase with negative profitability and a search for a new CEO. While the strategic pivot to margin over growth is necessary, the financial results are currently weak, warranting a hold until there is evidence of successful margin restoration.

Keywords

agilon health, value-based care, Medicare Advantage, proxy statement, primary care, healthcare technology